Eastern Europe and Balkan Region Refresher Course on Breast Cancer

Chairs: A. Eniu, RO - E. Senkus, PL
Host Chair: W. Wysocki, PL


The Refresher Course on Breast Cancer has been designed for medical and clinical oncologists who have attended a previous edition of the Eastern Europe and Balkan Region Masterclass in Medical/Clinical Oncology and other practicing oncologists of the region with the aim to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field of breast cancer.
The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced breast cancer. Moreover, spotlight lectures will discuss specific issues related to particular situations such as breast cancer in young women or survivorship issues.
Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty with interactive voting.


LEARNING OBJECTIVES
• Update on the latest advances in diagnostic procedures
• Update on the latest advances and on the state-of- the-art treatment options
• Learn about the management of specific situations
• Debate controversies and challenges in breast cancer treatment
• Improve practical skills in multidisciplinary management and follow-up of breast cancer patients
• Receive insights on the best approaches in organizing breast cancer care (breast cancer units)


MAIN TOPICS
• Update on standard and new diagnostic, treatment options and approaches
• Signalling pathways
• Breast cancer pathology and molecular biology
• Systemic treatment of early and advanced breast cancer

ORGANISING SECRETARIAT
Laura Richetti
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 51
e-mail: lrichetti@eso.net


OFFICIAL LANGUAGE
The official language will be English. No translation will be available.


CME ACCREDITATION
The Refresher course on Breast Cancer is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The Refresher course on Breast Cancer is granted with 9 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

FACULTY
F. Cardoso, Champalimaud Clinical Center, Lisbon, PT
G. Curigliano, European Institute of Oncology, Milan, IT
A. Eniu, Cancer Institute Ion Chiricuta, Cluj-Napoca, RO
A. Kołacińska, Medical University of Lodz, Lodz, PL
A. Lacko, Wroclaw University of Medicine, Wroklaw, PL
E. Senkus, Medical University of Gdańsk, Gdańsk, PL
P. Steyerova, General University Hospital Prague, Prague, CZ
G. Viale, European Institute of Oncology, Milan, IT
W. Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Krakow, PL

 

 5 October

18:00		Registration

 

 6 October

DIAGNOSIS AND LOCAL THERAPY    Chairs: P. Steyerova, CZ and W. Wysocki, PL
8:30		Imaging breast cancer: from diagnosis to response evaluation P. Steyerova, CZ
8:50		Discussion
9:00		Molecular biology and traditional pathology: hand in hand G. Viale, IT
9:20		Discussion
9:30		Breast cancer surgery: Understanding when less is more for the patient (including reconstruction)    A. Kołacińska, PL
9:50		Discussion
10:00		Personalized radiotherapy: more, less or differently? E. Senkus, PL
10:20		Discussion
10:30		Coffee break
SYSTEMIC THERAPY OF EARLY BREAST CANCER         Chair: F. Cardoso, PT and A. Eniu, RO
11:00		Optimizing strategy of adjuvant hormonal therapy in pre- and postmenopausal early breast cancer F. Cardoso, PT
11:20		Discussion
11:30		Adjuvant chemotherapy in luminal  breast cancer: who needs it, and how much? G. Curigliano, IT
11:50		Discussion
12:00		Update on HER2-directed and cytotoxic adjuvant therapy A. Lacko, PL
12:20		Discussion
12:30		Making best use of neoadjuvant systemic therapy in locally advanced breast cancer A. Eniu, RO
12:50		Discussion
13:15		Lunch
TREATMENT OF METASTATIC DISEASE        Chairs: G. Curigliano, IT and E. Senkus, PL
14:15		Optimizing  the treatment sequence of systemic therapy in triple- negative and HER2 positive breast cancer     G. Curigliano, IT
14:35		Discussion
14:45		Are we better in treating hormone-responsive metastatic breast cancer in 2016? Role of CDK 4/6 among the classical hormonal interventions F. Cardoso, PT
15:30		Discussion
15:45		Local therapy in metastatic disease: hoping for cure or just a sophisticated palliation? E. Senkus, PL
16:05		Discussion
16:10		Coffee break
16:30		Tumour board: Selected clinical cases presented by participants and discussed by the Faculty
19:00		Dinner

 

 7 October

PARTICULAR ISSUES IN BREAST CANCER MANAGEMENT    Chairs: F. Cardoso, PT and G. Curigliano, IT
9:00		Keynote lecture: New therapeutic approaches for breast cancer: established signaling pathways and immune therapy    G. Curigliano, IT
9:20		Discussion
9:30		Breast Cancer in Young Women: specific recommendations, fertility and pregnancy F. Cardoso, PT
9:50		Discussion
10:00		Survivorship issues in  both early and advanced breast cancer patients A. Lacko, PL
10:20		Discussion
10:30		Access to care: towards better use of resources by taking into consideration clinical benefit        A. Eniu, RO
11:00		Discussion
11:15		Coffee break
11:30		Keynote lecture Integrating multidisciplinarity: the concept of the Breast Units and  Multidisciplinary Care F. Cardoso
11:50		Discussion
12:00		Tumour board. Selected clinical cases presented by participants and discussed by the Faculty
13:30		Closing remarks     E. Senkus, PL - A. Eniu, PL
13:50		Lunch